These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8889900)

  • 21. Comparative distribution, pharmacokinetics and placental permeabilities of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-4-oxo-retinoic acid, retinyl acetate and 9-cis-retinal in hamsters.
    Howard WB; Willhite CC; Omaye ST; Sharma RP
    Arch Toxicol; 1989; 63(2):112-20. PubMed ID: 2730336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G; Thiel R; Chahoud I; Nau H
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A physiologically based pharmacokinetic model for retinoic acid and its metabolites.
    Clewell HJ; Andersen ME; Wills RJ; Latriano L
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S77-85. PubMed ID: 9091511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: possible implications for teratogenesis.
    Eckhoff C; Nau H
    Arch Toxicol; 1990; 64(6):502-3. PubMed ID: 2275606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.
    Pershing LK; Nelson JL; Corlett JL; Shrivastava SP; Hare DB; Shah VP
    J Am Acad Dermatol; 2003 May; 48(5):740-51. PubMed ID: 12734504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of vitamin A: recent results.
    Wiegand UW; Hartmann S; Hummler H
    Int J Vitam Nutr Res; 1998; 68(6):411-6. PubMed ID: 9857270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of the retinoids.
    Lucek RW; Colburn WA
    Clin Pharmacokinet; 1985; 10(1):38-62. PubMed ID: 3882304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maternal and fetal retinoid assay. Two case reports of isotretinoin (Roaccutane) exposure].
    Pons JC; Ville Y; Imbert MC; Thomas A; Frydman R; Benifla JL
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):274-6. PubMed ID: 8767225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Teratogenic effects of vitamin A and its derivates].
    Guillonneau M; Jacqz-Aigrain E
    Arch Pediatr; 1997 Sep; 4(9):867-74. PubMed ID: 9345570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoids: an overview of pharmacokinetics and therapeutic value.
    Gollnick H; Ehlert R; Rinck G; Orfanos CE
    Methods Enzymol; 1990; 190():291-304. PubMed ID: 2150872
    [No Abstract]   [Full Text] [Related]  

  • 31. Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: risk of vitamin A exposure in humans.
    Tzimas G; Collins MD; Bürgin H; Hummler H; Nau H
    J Nutr; 1996 Sep; 126(9):2159-71. PubMed ID: 8814204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin A teratogenicity and risk assessment in the macaque retinoid model.
    Hendrickx AG; Peterson P; Hartmann D; Hummler H
    Reprod Toxicol; 2000; 14(4):311-23. PubMed ID: 10908834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy.
    Nau H; Tzimas G; Mondry M; Plum C; Spohr HL
    Life Sci; 1995; 57(1):53-60. PubMed ID: 7596221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization.
    Rühl R; Plum C; Elmazar MM; Nau H
    Toxicol Sci; 2001 Sep; 63(1):82-9. PubMed ID: 11509747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin.
    Rollman O; Vahlquist A
    J Invest Dermatol; 1986 Apr; 86(4):384-9. PubMed ID: 2943822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients.
    Muindi JR; Roth MD; Wise RA; Connett JE; O'Connor GT; Ramsdell JW; Schluger NW; Romkes M; Branch RA; Sciurba FC;
    J Clin Pharmacol; 2008 Jan; 48(1):96-107. PubMed ID: 18094222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The teratogenic metabolites of vitamin A in women following supplements and liver.
    Buss NE; Tembe EA; Prendergast BD; Renwick AG; George CF
    Hum Exp Toxicol; 1994 Jan; 13(1):33-43. PubMed ID: 8198828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
    Brazzell RK; Colburn WA
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoids and acne.
    Leyden JJ
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):164-8. PubMed ID: 2970475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tretinoin: a review of the nonclinical developmental toxicology experience.
    Kochhar DM; Christian MS
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S47-59. PubMed ID: 9091508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.